Kurokawa K, Haussler M R
Endocrinology. 1978 Jun;102(6):1864-6. doi: 10.1210/endo-102-6-1864.
The effect of hypomagnesemia occurring in phosphate deprivation on elevated levels of plasma 1,25-dihydroxycholecalciferol (1,25(OH)2D3) was evaluated in rats. Phosphate deprivation was associated with an elevated plasma 1,25(OH)2D3, hypophosphatemia, and hypomagnesemia. With oral magnesium supplement during phosphate deprivation, plasma magnesium did not fall, but plasma inorganic phosphate fell and 1,25(OH)2D3 rose to comparable levels seen in phosphate-deprived rats lacking magnesium supplement. These results indicate that a rise in plasma 1,25(OH)2D3 during phosphate deprivation is not due to concomitant hypomagnesemia and support the postulate that phosphate deprivation per se is responsible for the elevated plasma 1,25(OH)2D3.
在大鼠中评估了磷缺乏时发生的低镁血症对血浆1,25 - 二羟胆钙化醇(1,25(OH)2D3)水平升高的影响。磷缺乏与血浆1,25(OH)2D3升高、低磷血症和低镁血症相关。在磷缺乏期间口服补充镁,血浆镁没有下降,但血浆无机磷下降,且1,25(OH)2D3升高至与缺乏镁补充的磷缺乏大鼠中所见相当的水平。这些结果表明,磷缺乏期间血浆1,25(OH)2D3升高并非由于伴随的低镁血症,并支持以下假设,即磷缺乏本身导致血浆1,25(OH)2D3升高。